Initially, for a comprehensive demonstration of SMARCAL1 expression profiles in tumor and adjacent tissues, we observed elevated levels of SMARCAL1 expression across multiple tumor cell lines, notably in the bowel, uterus, lymphoid, lung, liver, and brain as documented in the CCLE dataset (Fig. 1A). This evidence concerns the gene SMARCAL1 and neoplasm.